ClassID:

95253

C07D403/14 - page 12 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings

Recent Application in this class:
#3301
20150166578
2015-06-18

Pyrrolidine derivatives and their use as complement pathway modulators

#3302
20150166564
2015-06-18

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

#3303
20150166533
2015-06-18

NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH BENZIMIDAZOLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

#3304
20150166529
2015-06-18

Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer

#3305
20150166527
2015-06-18

Benzimidazole-proline derivatives

#3306
20150166526
2015-06-18

Modulators of calcium release-activated calcium channel

#3307
20150166514
2015-06-18

Inhibitors of HCV NS5A

#3308
20150166513
2015-06-18

Heterocyclyl pyrimidine analogues as TYK2 inhibitors

#3309
20150166486
2015-06-18

Substituted diazine and triazine spleen tyrosine kinease (Syk) inhibitors

#3310
20150165063
2015-06-18

1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment

#3311
20150162544
2015-06-11

Compound and organic light-emitting device comprising the compound

#3312
20150159288
2015-06-11

Additives for electroplating baths

#3313
20150158909
2015-06-11

ANTI-VIRAL COMPOUNDS

#3314
20150158876
2015-06-11

Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors

#3315
20150158851
2015-06-11

PYRAZOLE CARBOXAMIDE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

#3316
20150158847
2015-06-11

Tropomyosin-related kinase (TRK) inhibitors

#3317
20150158828
2015-06-11

Heterocyclic compounds useful for kinase inhibition

#3318
20150158823
2015-06-11

2,4-Pyrimidinediamine compounds and their uses

#3319
20150157741
2015-06-11

Compound and photoacoustic imaging contrast medium containing the compound

#3320
20150152112
2015-06-04

Pyridinone and pyrimidinone derivatives as factor Xia

#3321
20150152089
2015-06-04

COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION

#3322
20150152077
2015-06-04

SecA inhibitors and methods of making and using thereof

#3323
20150152069
2015-06-04

N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer

#3324
20150152048
2015-06-04

Substituted pyrrolidines as factor xia inhibitors for the treatment thromboembolic diseases

#3325
20150148381
2015-05-28

Substituted dihydropyrazolones for treating cardiovascular and hematological diseases

#3326
20150148374
2015-05-28

Complement pathway modulators and uses thereof

#3327
20150148361
2015-05-28

Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine H4 receptor

#3328
20150148349
2015-05-28

Complement pathway modulators and uses thereof

#3329
20150141659
2015-05-21

Solid forms of an antiviral compound

#3330
20150141480
2015-05-21

Carbohydrate-selective receptors

#3331
20150141396
2015-05-21

Pyrimidine pyrazolyl derivatives

#3332
20150137027
2015-05-21

Graphene nanodispersion and method for preparing same

#3333
20150133677
2015-05-14

Synthesis of chiral 2-(1H-indazol-6-yl)-spiro[cyclopropane-1,3′-indolin]-2′-ones

#3334
20150133662
2015-05-14

NOVEL ORGANIC ELECTROLUMINESCENCE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME

#3335
20150133473
2015-05-14

Ring-substituted N-pyridinyl amides as kinase inhibitors

#3336
20150133452
2015-05-14

Pyrimidinyl-pyridazinone derivatives for treating a disease which is influenced by inhibition of met kinase

#3337
20150133451
2015-05-14

Heterocyclic compound

#3338
20150133422
2015-05-14

4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use

#3339
20150126736
2015-05-07

NOVEL ORGANIC ELECTROLUMINESCENCE COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE CONTAINING THE SAME

#3340
20150126570
2015-05-07

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3341
20150126550
2015-05-07

Pharmaceutical uses of 6-amino quinazoline or 3-cyano quinoline derivatives

#3342
20150126514
2015-05-07

Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

#3343
20150126512
2015-05-07

Modulators of TNF-α signaling

#3344
20150126500
2015-05-07

Piperazinyl pyrimidine derivatives, preparation method and use thereof

#3345
20150126499
2015-05-07

Triazole compounds that modulate HSP90 activity

#3346
20150126492
2015-05-07

Complement pathway modulators and uses thereof

#3347
20150126491
2015-05-07

Pyridazine derivatives as RORc modulators

#3348
20150125388
2015-05-07

Molecular probes for multimodality imaging and tracking of stem cells

#3349
20150119405
2015-04-30

Inhibitors of the fibroblast growth factor receptor

#3350
20150112065
2015-04-23

Pyrazine derivative, and light emitting element, display device, electronic device using the pyrazine derivative

#3351
20150112063
2015-04-23

PROCESS OF PREPARATION OF AZIMSULFURON

#3352
20150111888
2015-04-23

Small compounds targeting TACC3

#3353
20150111887
2015-04-23

Compositions useful for treating disorders related to KIT

#3354
20150111875
2015-04-23

Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#3355
20150111874
2015-04-23

Heterocyclic compounds and uses thereof

#3356
20150111868
2015-04-23

NOVEL 1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES SUBSTITUTED WITH HETEROCYCLES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS

#3357
20150111857
2015-04-23

Compositions useful for treating disorders related to kit

#3358
20150105549
2015-04-16

Intermediates to prepare herbicidal pyrimidone derivatives

#3359
20150105375
2015-04-16

METHODS FOR TREATING PULMONARY EMPHYSEMA USING SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

#3360
20150105370
2015-04-16

Selectively substituted quinoline compounds

#3361
20150105368
2015-04-16

Pyrazolyl quinoxaline kinase inhibitors

#3362
20150099875
2015-04-09

Methods of regioselective synthesis of 2,4-disubstituted pyrimidines

#3363
20150099779
2015-04-09

ROR modulators and their uses

#3364
20150099757
2015-04-09

Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders

#3365
20150099756
2015-04-09

Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2

#3366
20150099748
2015-04-09

Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin Dmediated diseases

#3367
20150099730
2015-04-09

IMIDAZOLIN-5-ONE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER

#3368
20150099277
2015-04-09

Tetrazines and method of synthezising the same

#3369
20150094298
2015-04-02

Inhibitors of protein kinases

#3370
20150094296
2015-04-02

Heterocyclic compound

#3371
20150094294
2015-04-02

COMPOUNDS AND METHODS FOR TREATING MALARIA

#3372
20150087835
2015-03-26

Process for the preparation of vilazodone hydrochloride and its amorphous form

#3373
20150087827
2015-03-26

Method for the preparation of triazole compounds

#3374
20150087663
2015-03-26

Substituted aminopyrimidine compounds and methods of use

#3375
20150087658
2015-03-26

Substituted aminopyrimidine compounds and methods of use

#3376
20150087645
2015-03-26

Therapeutic piperazines

#3377
20150087618
2015-03-26

Anti-viral compounds

#3378
20150087509
2015-03-26

Substituted pyrazole-containing compounds and their use as pesticides

#3379
20150084031
2015-03-26

Polymerizable monomer, and material for organic device, hole injection/transport material, material for organic electroluminescence element and organic electroluminescent element each comprising polymer (polymeric compound) of the polymerizable monomer

#3380
20150080392
2015-03-19

Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament

#3381
20150080364
2015-03-19

Carbamate compounds and of making and using same

#3382
20150079028
2015-03-19

Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof

#3383
20150078998
2015-03-19

Radiolabeled prostate specific membrane antigen inhibitors

#3384
20150076483
2015-03-19

Organic electroluminescent element, organic electroluminescent lighting device and organic electroluminescent display device

#3385
20150073139
2015-03-12

Pesticidal arylpyrrolidines

#3386
20150073026
2015-03-12

1, 2, 4-triazole derivatives and their anti-microbial activity

#3387
20150072991
2015-03-12

Oligooxopiperazines and methods of making and using them

#3388
20150072959
2015-03-12

Substituted triazoles useful as Axl inhibitors

#3389
20150071878
2015-03-12

Inhibitors of hepatitic C virus

#3390
20150065542
2015-03-05

ANTI-VIRAL COMPOUNDS

#3391
20150065520
2015-03-05

Substituted indazole derivatives active as kinase inhibitors

#3392
20150065505
2015-03-05

Pyrimidinone carboxamide inhibitors of endothelial lipase

#3393
20150065447
2015-03-05

SURVIVAL BENEFIT IN PATIENTS WITH SOLID TUMORS WITH ELEVATED C-REACTIVE PROTEIN LEVELS

#3394
20150064196
2015-03-05

Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof

#3395
20150060824
2015-03-05

Organic compound, light-emitting element, light-emitting device, electronic device, and lighting device

#3396
20150060801
2015-03-05

Organic electroluminescent element and material for organic electroluminescent elements

#3397
20150057449
2015-02-26

Nonpolar phase-soluble metathesis catalysts

#3398
20150057295
2015-02-26

6-Alkynyl Pyridine

#3399
20150057292
2015-02-26

Substituted indazole derivatives active as kinase inhibitors

#3400
20150057291
2015-02-26

Substituted indazole derivatives active as kinase inhibitors

#3401
20150057286
2015-02-26

Bis-amido pyridines

#3402
20150057285
2015-02-26

Benzyl substituted triazine derivatives and their therapeutical applications

#3403
20150057260
2015-02-26

ALKYNYL ALCOHOLS AND METHODS OF USE

#3404
20150057218
2015-02-26

INHIBITORS OF HCV NS5A

#3405
20150053939
2015-02-26

Organic electroluminescent materials and devices

#3406
20150051238
2015-02-19

Pyrazole aminopyrimidine derivatives as LRRK2 modulators

#3407
20150051237
2015-02-19

Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors

#3408
20150051203
2015-02-19

TRIAZOLE DERIVATIVES AS HSP90 INHIBITORS

#3409
20150051196
2015-02-19

Inhibitors of c-fms kinase

#3410
20150051187
2015-02-19

Substituted pyrazines as ATR kinase inhibitors

#3411
20150045339
2015-02-12

Nitrogen-containing heterocyclic compound or salt thereof

#3412
20150041784
2015-02-12

Compound, light-emitting material, and organic light-emitting device

#3413
20150038510
2015-02-05

Cinnoline derivatives

#3414
20150038501
2015-02-05

INHIBITORS OF HCV NS5A

#3415
20150038486
2015-02-05

Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy

#3416
20150038460
2015-02-05

6,5-Heterocyclic Propargylic Alcohol Compounds and Uses Therefor

#3417
20150034938
2015-02-05

Compound for organic optoelectronic device, organic light emitting diode including the same and display including the organic light emitting diode

#3418
20150031884
2015-01-29

ANTI-VIRAL COMPOUNDS

#3419
20150031698
2015-01-29

s-Triazine compounds, pharmaceutical compositions and methods of using the same

#3420
20150031685
2015-01-29

Substituted heterocyclic acetamides as kappa opioid receptor (KOR) agonists

#3421
20150031670
2015-01-29

Cyclic amides as MetAP-2 inhibitors

#3422
20150031661
2015-01-29

Substituted pyrazin-2-amines as inhibitors of ATR kinase

#3423
20150023913
2015-01-22

Hepatitis C Virus Inhibitors

#3424
20150018376
2015-01-15

PYRIMIDIN-4-YL)OXY)-1H-INDOLE-1-CARBOXAMIDE DERIVATIVES AND USE THEREOF

#3425
20150018364
2015-01-15

Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics

#3426
20150018363
2015-01-15

Benzimidazole derivatives as MCH receptor antagonists

#3427
20150018334
2015-01-15

Inhibitors of leukotriene production

#3428
20150018332
2015-01-15

Nuclear transport modulators and uses thereof

#3429
20150018313
2015-01-15

5-substituted benzimidazolium compounds

#3430
20150011754
2015-01-08

Hepatitis C virus inhibitors

#3431
20150011752
2015-01-08

Triazine compounds as PI3 kinase and MTOR inhibitors

#3432
20150011575
2015-01-08

Methods and compositions for modulating Ire1, SRC and ABL activity

#3433
20150011553
2015-01-08

Pesticidal arylpyrrolidines

#3434
20150011548
2015-01-08

Protein kinase inhibitors

#3435
20150011534
2015-01-08

Pyridazinone derivatives

#3436
20150008423
2015-01-08

Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same

#3437
20150006445
2015-01-01

Pathway analysis for identification of diagnostic tests

#3438
20150005297
2015-01-01

2,4-pyrimidinediamine compounds and their uses

#3439
20150005294
2015-01-01

Azaheterocyclic compounds

#3440
20150005293
2015-01-01

5-membered heterocyclic amides and related compounds

#3441
20150005281
2015-01-01

PYRIMIDINE-2,4-DIAMINE DERIVATIVES AS KINASE INHIBITORS

#3442
20150005279
2015-01-01

Primary carboxamides as BTK inhibitors

#3443
20150004731
2015-01-01

Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative

#3444
20150001521
2015-01-01

Organic compound and organic electroluminescent device employing the same

#3445
20140378488
2014-12-25

4-substituted-(3-substituted-1H-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof

#3446
20140378485
2014-12-25

Substituted quinazolinones as HCV inhibitors

#3447
20140378474
2014-12-25

5-membered heteroarylcarboxamide derivatives as plasma kallikrein inhibitors

#3448
20140378442
2014-12-25

Phthalazinone derivatives

#3449
20140377223
2014-12-25

SUBSTITUTED BIPHENYLENE COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

#3450
20140371455
2014-12-18

Chemical compounds

#3451
20140371138
2014-12-18

Inhibitors of hepatitis C virus replication

#3452
20140364617
2014-12-11

ANTI-VIRAL COMPOUNDS

#3453
20140364616
2014-12-11

ANTI-VIRAL COMPOUNDS

#3454
20140364610
2014-12-11

COMPOUND SUITABLE FOR THE TREATMENT OF SYNUCLEOPATHIES

#3455
20140364585
2014-12-11

Immunoconjugates, compositions for making them, and methods of making and use

#3456
20140364431
2014-12-11

Quinoline and cinnoline derivatives and their applications

#3457
20140364429
2014-12-11

Antiviral compounds highly effective as HCV-NS5A inhibitor

#3458
20140364392
2014-12-11

Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease

#3459
20140361254
2014-12-11

Heterocyclic compound and organic light-emitting device comprising the same

#3460
20140357687
2014-12-04

Pyrazol-3-ones that activate pro-apoptotic BAX

#3461
20140357653
2014-12-04

Chemical compounds

#3462
20140357626
2014-12-04

Hetero-bicyclic derivatives as HCV inhibitors

#3463
20140357551
2014-12-04

Organic compounds and their uses

#3464
20140353650
2014-12-04

Material for organic electroluminescent element and organic electroluminescent element using same

#3465
20140350247
2014-11-27

Aryl-amine derivative and organic electroluminescent device using the same as a hole transport material

#3466
20140350016
2014-11-27

Potent and selective inhibitors of hepatitis C virus

#3467
20140349996
2014-11-27

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#3468
20140349973
2014-11-27

Metalloenzyme inhibitor compounds

#3469
20140348746
2014-11-27

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

#3470
20140343286
2014-11-20

ANTI-VIRAL COMPOUNDS

#3471
20140343083
2014-11-20

Pyrrolidine derivatives, pharmaceutical compositions and uses thereof

#3472
20140343077
2014-11-20

Hepatitis C inhibitor compounds

#3473
20140343066
2014-11-20

5-substituted indazoles as kinase inhibitors

#3474
20140343038
2014-11-20

1,2,4-triazine-6-carboxamide derivative

#3475
20140343030
2014-11-20

Bipyrazole derivatives as JAK inhibitors

#3476
20140343018
2014-11-20

Anti-depression compounds

#3477
20140341851
2014-11-20

Benzimidazole derivatives

#3478
20140336379
2014-11-13

Organic light-emitting device, and delayed fluorescent material and compound used therefor

#3479
20140336374
2014-11-13

Process and intermediates for the production of CCR2 antagonists

#3480
20140336211
2014-11-13

Crystalline forms of 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [ (S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl ]-amide

#3481
20140336195
2014-11-13

Aryloxmethyl cyclopropane derivatives as PDE10 inhibitors

#3482
20140336172
2014-11-13

-indazoles as EPreceptor antagonists

#3483
20140330025
2014-11-06

Monoamine compound, charge transport material, composition for charge transport film, organic electroluminescent element, organic EL display, and organic EL lighting

#3484
20140330007
2014-11-06

2,4-pyrimidinediamine compounds and their uses

#3485
20140329823
2014-11-06

Dimeric IAP inhibitors

#3486
20140329819
2014-11-06

Insecticidal triazinone derivatives

#3487
20140329798
2014-11-06

Substituted cyclopropyl compounds useful as GPR119 agonists

#3488
20140328805
2014-11-06

Biheteroaryl compounds and uses thereof

#3489
20140323490
2014-10-30

Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

#3490
20140323465
2014-10-30

HCV protease inhibitors and uses thereof

#3491
20140323463
2014-10-30

Pyrazinecarboxamide compound

#3492
20140323458
2014-10-30

Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infections

#3493
20140323448
2014-10-30

sGC STIMULATORS

#3494
20140323418
2014-10-30

SELECTIVE KINASE INHIBITORS

#3495
20140316143
2014-10-23

Processes for the preparation of novel benzimidazole derivatives

#3496
20140315882
2014-10-23

Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof

#3497
20140315856
2014-10-23

Aminopyrazole derivative

#3498
20140315792
2014-10-23

Anti-viral compounds

#3499
20140312331
2014-10-23

Biscarbazole derivatives and organic electroluminescence device employing the same

#3500
20140309259
2014-10-16

Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents

#3501
20140309240
2014-10-16

Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents

#3502
20140309215
2014-10-16

4-aminoquinazolin-2-yl-1-pyrrazole-4-carboxylic acid compounds as prolyl hydroxylase inhibitors

#3503
20140309210
2014-10-16

INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

#3504
20140309209
2014-10-16

Pyrazine kinase inhibitors

#3505
20140306207
2014-10-16

Organic electroluminescence element, and material for organic electroluminescence element

#3506
20140303164
2014-10-09

THERAPEUTIC COMPOUNDS

#3507
20140303154
2014-10-09

2,4-pyridinediamine compounds and their uses

#3508
20140296524
2014-10-02

Halogenated compounds for photodynamic therapy

#3509
20140296514
2014-10-02

Aryl- and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#3510
20140296511
2014-10-02

Halogenated compounds for photodynamic therapy

#3511
20140296206
2014-10-02

Compositions useful for treating disorders related to kit

#3512
20140291654
2014-10-02

Heterocyclic compound and organic light-emitting device including the same

#3513
20140288301
2014-09-25

TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

#3514
20140288063
2014-09-25

Heterocyclic substituted pyrimidine compound

#3515
20140288050
2014-09-25

Modulators of opioid receptors and methods of use thereof

#3516
20140288048
2014-09-25

Heterocyclic compounds and uses thereof

#3517
20140275555
2014-09-18

Articles and methods comprising persistent carbenes and related compositions

#3518
20140275121
2014-09-18

CDC7 inhibitors

#3519
20140275118
2014-09-18

Substituted 2-azabicycles and their use as orexin receptor modulators

#3520
20140275087
2014-09-18

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

#3521
20140275086
2014-09-18

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

#3522
20140275077
2014-09-18

Uracil derivatives as AXL and c-MET kinase inhibitors

#3523
20140275076
2014-09-18

Heterocyclic substituted-3-heteroarylidenyl-2-indolinone derivative

#3524
20140275074
2014-09-18

Heterocyclic derivative having PGD2 receptor antagonist activity

#3525
20140275059
2014-09-18

DNA-PK inhibitors

#3526
20140275029
2014-09-18

1,2,6-substituted benzimidazoles as FLAP modulators

#3527
20140275025
2014-09-18

Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

#3528
20140275024
2014-09-18

Substituted quinoxaline DNA-PK inhibitors

#3529
20140256734
2014-09-11

Pyridinyl and fused pyridinyl triazolone derivatives

#3530
20140256722
2014-09-11

Benzoimidazoles as prolyl hydroxylase inhibitors

#3531
20140256708
2014-09-11

1,3 substituted azetidine PDE10 inhibitors

#3532
20140256707
2014-09-11

Heteroaryl sodium channel inhibitors

#3533
20140256703
2014-09-11

AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES

#3534
20140256684
2014-09-11

Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases

#3535
20140255306
2014-09-11

Triazine based radiopharmaceuticals and radioimaging agents

#3536
20140249151
2014-09-04

Bicyclic heterocyclic compound

#3537
20140249137
2014-09-04

Pyrimidine compounds as tuberculosis inhibitors

#3538
20140249135
2014-09-04

PIM KINASE INHIBITORS AND METHODS OF THEIR USE

#3539
20140249134
2014-09-04

Triazolyl PDE10 inhibitors

#3540
20140249074
2014-09-04

Antiviral compounds

#3541
20140243534
2014-08-28

Halogenated compounds for Photodynamic therapy

#3542
20140243305
2014-08-28

Azetidinyl diamides as monoacylglycerol lipase inhibitors

#3543
20140231794
2014-08-21

Material for organic electroluminescent element, and organic electroluminescent element produced using same

#3544
20140228566
2014-08-14

Quinoxaline derivative, and light emitting element, light emitting device, and electronic device using the quinoxaline derivative

#3545
20140228362
2014-08-14

Method of treatment or prophylaxis

#3546
20140228359
2014-08-14

Bis-indolic derivatives, their uses in particular as antibacterials

#3547
20140228351
2014-08-14

Substituted indazole derivatives active as kinase inhibitors

#3548
20140228320
2014-08-14

Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors

#3549
20140225040
2014-08-14

Compounds for electronic devices

#3550
20140221374
2014-08-07

RAF KINASE INHIBITORS

#3551
20140221362
2014-08-07

Heterocyclic compounds as pesticides

#3552
20140221347
2014-08-07

Therapeutic compounds

#3553
20140221346
2014-08-07

THERAPEUTIC COMPOUNDS

#3554
20140221336
2014-08-07

COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASES

#3555
20140221310
2014-08-07

Flap modulators

#3556
20140213704
2014-07-31

NEW TRIAZINE DERIVATIVE AND ULTRAVIOLET ABSORBER

#3557
20140213572
2014-07-31

UNSATURATED NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS

#3558
20140213570
2014-07-31

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#3559
20140212509
2014-07-31

Inhibitors of poly(ADP-ribose)polymerase

#3560
20140206862
2014-07-24

Antioxidant small molecules aimed at targeting metal-based oxidative stress in neurogenerative disorders

#3561
20140206706
2014-07-24

Five-membered heterocycles useful as serine protease inhibitors

#3562
20140206676
2014-07-24

Substituted 4-(1H-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of mAChR Mreceptors

#3563
20140206664
2014-07-24

Heterocycle amido alkyloxy substituted quinazoline derivative and use thereof

#3564
20140205564
2014-07-24

Hepatitis C Virus Inhibitors

#3565
20140200333
2014-07-17

DENDRON REPORTER MOLECULES

#3566
20140200226
2014-07-17

Anti-malarial compounds from marine natural products

#3567
20140194483
2014-07-10

Inhibitors for steroid response elements and RNA polymerase II and related methods

#3568
20140194481
2014-07-10

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3569
20140194425
2014-07-10

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#3570
20140194407
2014-07-10

Antiplatelet agent

#3571
20140194406
2014-07-10

Alkynyl substituted pyrimidinyl-pyrroles active as kinases inhibitors

#3572
20140193363
2014-07-10

NOVEL BENZIMIDAZOLE DERIVATIVES

#3573
20140187781
2014-07-03

AMINOPYRIDINES AND AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES

#3574
20140187772
2014-07-03

PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS

#3575
20140187543
2014-07-03

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

#3576
20140187540
2014-07-03

Compounds and methods of use thereof for treating neurodegenerative disorders

#3577
20140183500
2014-07-03

Oxygen-containing fused ring amine compound, sulfur-containing fused ring amine compound and organic electroluminescence device

#3578
20140179689
2014-06-26

Rho kinase inhibitors and methods of use

#3579
20140179673
2014-06-26

Phosphatidylinositol 3-kinase inhibitors

#3580
20140179670
2014-06-26

Uracil derivative and use thereof for medical purposes

#3581
20140179668
2014-06-26

Fused pyrimidine compounds and use thereof

#3582
20140179667
2014-06-26

Aryl and heteroaryl fused lactams

#3583
20140179666
2014-06-26

Bicyclic heterocycle compounds and their uses in therapy

#3584
20140179664
2014-06-26

Heterocyclyl Pyrimidine Analogues As JAK Inhibitors

#3585
20140179662
2014-06-26

Pharmaceutically active disubstituted triazine derivatives

#3586
20140179623
2014-06-26

Ectoparasiticidal active substance combinations

#3587
20140178304
2014-06-26

Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals

#3588
20140171536
2014-06-19

Dental restorative materials based on polymerizable azides and alkynes

#3589
20140171476
2014-06-19

Chemica compounds

#3590
20140171431
2014-06-19

AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE

#3591
20140171430
2014-06-19

Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators

#3592
20140171420
2014-06-19

Diazole lactams

#3593
20140170111
2014-06-19

Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases

#3594
20140163237
2014-06-12

Bipolar hosts for light emitting devices

#3595
20140162999
2014-06-12

PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#3596
20140162998
2014-06-12

PIM kinase inhibitors and preparation methods and use in medicinal manufacture thereof

#3597
20140162984
2014-06-12

Phosphonoxy quinazoline derivatives and their pharmaceutical use

#3598
20140162983
2014-06-12

Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity

#3599
20140161801
2014-06-12

Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof

#3600
20140158999
2014-06-12

Compound for organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode